Barry J. Moze
2020
Compensation breakdown
| Non-Equity Incentive Plan | $1,004,752 |
|---|---|
| Salary | $628,960 |
| Stock Awards | $3,364,507 |
| Other | $75,659 |
| Total | $5,073,877 |
Moze received $3.4M in stock awards, accounting for 66% of the total pay in 2020.
Moze also received $1M in non-equity incentive plan, $629K in salary and $75.7K in other compensation.
Rankings
In 2020, Barry J. Moze's compensation ranked 2,177th out of 13,090 executives tracked by ExecPay. In other words, Moze earned more than 83.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,177 out of 13,090 | 83rd |
Division Manufacturing | 836 out of 5,617 | 85th |
Major group Chemicals And Allied Products | 299 out of 2,248 | 87th |
Industry group Drugs | 254 out of 1,948 | 87th |
Industry Pharmaceutical Preparations | 182 out of 1,453 | 88th |
Pay ratio
| Barry J. Moze's Pay | $5,073,877 |
|---|---|
| Median Employee's Pay | $298,446 |
| Pay Ratio | 17to 1 |
In 2020, the annual total compensation of Barry J. Moze was $5,073,877.
The annual total compensation of the median employee at Horizon Pharma was $298,446.
The ratio of Barry J. Moze's pay to the pay of median employee was therefore 17 to one.
Moze's colleagues
We found five more compensation records of executives who worked with Barry J. Moze at Horizon Pharma in 2020.
2020
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2020
Paul Hoelscher
Horizon Pharma
Chief Financial Officer
2020
Andy Pasternak
Horizon Pharma
Executive Vice President, Chief Strategy Officer
2020
Jeffrey FACP
Horizon Pharma
Chief Medical Officer
2020
Brian Beeler
Horizon Pharma
General Counsel
News
March 17, 2022
March 17, 2021
March 18, 2020
April 8, 2019